67 related articles for article (PubMed ID: 11497291)
1. Localization of human BRCA1 and BRCA2 in non-inherited colorectal carcinomas and matched normal mucosas.
Bernard-Gallon DJ; Peffault de Latour M; Hizel C; Vissac C; Cure H; Pezet D; Dechelotte PJ; Chipponi J; Chassagne J; Bignon YJ
Anticancer Res; 2001; 21(3B):2011-20. PubMed ID: 11497291
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of BRCA1, BRCA2 and Hmsh2 mRNA expression in colorectal Lieberkühnien adenocarcinomas and matched normal mucosa: relationship with cellular proliferation.
Le Corre L; Vissac-Sabatier C; Chalabi N; Bignon YJ; Daver A; Chassevent A; Bernard-Gallon DJ
Anticancer Res; 2005; 25(3B):2009-16. PubMed ID: 16158938
[TBL] [Abstract][Full Text] [Related]
3. Expression of BRCA1 and BRCA2 in male breast cancers and gynecomastias.
Bernard-Gallon DJ; Déchelotte PJ; Le Corre L; Vissac-Sabatier C; Favy DA; Cravello L; De Latour MP; Bignon YJ
Anticancer Res; 2003; 23(1B):661-7. PubMed ID: 12680164
[TBL] [Abstract][Full Text] [Related]
4. Differential expressions of BRCA1 and BRCA2 in infantile gynecomastia.
Bernard-Gallon DJ; Dechelotte PJ; Le Corre L; Chalabi N; Vissac-Sabatier C; Bignon YJ
Anticancer Res; 2004; 24(1):321-4. PubMed ID: 15015615
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma.
Beger C; Ramadani M; Meyer S; Leder G; Krüger M; Welte K; Gansauge F; Beger HG
Clin Cancer Res; 2004 Jun; 10(11):3780-7. PubMed ID: 15173085
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.
Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Sánchez L; Rivas C; Benítez J
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3606-14. PubMed ID: 14506147
[TBL] [Abstract][Full Text] [Related]
7. Phytoestrogen-rich diets modulate expression of Brca1 and Brca2 tumor suppressor genes in mammary glands of female Wistar rats.
Vissac-Sabatier C; Coxam V; Déchelotte P; Picherit C; Horcajada MN; Davicco MJ; Lebecque P; Bignon YJ; Bernard-Gallon D
Cancer Res; 2003 Oct; 63(20):6607-12. PubMed ID: 14583453
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of homeodomain proteins DLX4, HB9 and HB24 in malignant and benign human colorectal tissues.
Hollington P; Neufing P; Kalionis B; Waring P; Bentel J; Wattchow D; Tilley WD
Anticancer Res; 2004; 24(2B):955-62. PubMed ID: 15161049
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells.
Gessi S; Cattabriga E; Avitabile A; Gafa' R; Lanza G; Cavazzini L; Bianchi N; Gambari R; Feo C; Liboni A; Gullini S; Leung E; Mac-Lennan S; Borea PA
Clin Cancer Res; 2004 Sep; 10(17):5895-901. PubMed ID: 15355922
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.
Toyoda A; Kawana H; Azuhata K; Yu J; Omata A; Kishi H; Higashi M; Harigaya K
Int J Oncol; 2009 Jan; 34(1):53-60. PubMed ID: 19082477
[TBL] [Abstract][Full Text] [Related]
13. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
16. Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers.
De Brakeleer S; Bogdani M; De Grève J; Decock J; Sermijn E; Bonduelle M; Goelen G; Teugels E
Mutat Res; 2007 Jun; 619(1-2):104-12. PubMed ID: 17445839
[TBL] [Abstract][Full Text] [Related]
17. Loss of nuclear BRCA1 localization in breast carcinoma is age dependent.
Bogdani M; Teugels E; De Grève J; Bourgain C; Neyns B; Pipeleers-Marichal M
Virchows Arch; 2002 Mar; 440(3):274-9. PubMed ID: 11889597
[TBL] [Abstract][Full Text] [Related]
18. Aneuploidy is associated with TP53 expression but not with BRCA1 or TERT expression in sporadic colorectal cancer.
Schjølberg AR; Clausen OP; Burum-Auensen E; De Angelis PM
Anticancer Res; 2009 Nov; 29(11):4381-7. PubMed ID: 20032382
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of BRCA1 and BRCA2 mRNA expression in sporadic breast carcinomas and its relationship with clinicopathological characteristics.
Egawa C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Jpn J Cancer Res; 2001 Jun; 92(6):624-30. PubMed ID: 11429050
[TBL] [Abstract][Full Text] [Related]
20. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
Yao CC; Lin CY; Hu MB
Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
